GW
TTPH

GW & Wade’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

GW & Wade’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-750
Closed -$103K – 244
2017
Q3 		$103K Hold
750
– – 0.01% 236
2017
Q2 		$107K Hold
750
– – 0.01% 230
2017
Q1 		$138K Buy
+750
New +$84.1K 0.02% 234
2015
Q3 		– Sell
-250
Closed -$237K – 245
2015
Q2 		$237K Buy
+250
New +$204K 0.05% 209

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GW & Wade's TTPH Position: Q4 2017 in Review

GW & Wade sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2017, closing a stake of 750 shares — an estimated $103K sold.

GW & Wade first reported a position in TTPH in Q2 2015 and held it in 4 quarters. The position peaked at $237K in Q2 2015. 103 funds tracked by Wall St. Rank hold TTPH as of Q4 2017.

  • GW & Wade reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • GW & Wade sold 750 Tetraphase Pharmaceuticals, Inc. shares in Q4 2017, an estimated $103K.
  • GW & Wade first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2015 and held it in 4 quarters.
  • GW & Wade's Tetraphase Pharmaceuticals, Inc. position peaked at $237K in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2017.

Based on GW & Wade's 13F filing for Q4 2017, filed 13 Feb 2018.